Clinical Trial Award - Selumentinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Young Children with Neurofibromatosis Type 1 (NF1)

Grant

Total Award Amount

  • 1181297.00
  • Direct Costs

  • 1000000.00
  • Sponsor Award Id

  • W81XWH2110796
  • Contributor

  • Bruce Korf M.D., Ph.D.   Principal Investigator  
  • Laura Metrock   Principal Investigator